<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03523832</url>
  </required_header>
  <id_info>
    <org_study_id>04</org_study_id>
    <nct_id>NCT03523832</nct_id>
  </id_info>
  <brief_title>Preemptive Analgesia in Total Knee Arthroplasty</brief_title>
  <official_title>Preemptive Analgesia in Total Knee Arthroplasty: Comparing the Effects of Single Dose Combined Celecoxib With Pregabaline and Repetition Dose Combined Celecoxib With Pregabaline (Double Blind Controlled Clinical Trial)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fakultas Kedokteran Universitas Indonesia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fakultas Kedokteran Universitas Indonesia</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Acute Pain is the most common early complication after total knee arthroplasty that caused
      delayed mobilization, demands of morphine, and higher operative cost. There were many
      researches that had been done in analgesia method to find the most effective analgesia,
      lowest side effect, and easy to apply. Preemptive analgesia of combined celecoxib and
      pregabalin were reported to give a promising outcome.

      In a randomized, double blind controlled clinical trial, 30 subjects underwent surgery for
      total knee arthroplasty using 15-20mg bupivacaine 5% epidural anesthesia. All subjects were
      divided into three groups. First group was given celecoxib 400mg and pregabaline 150mg 1 hour
      before operation, second group was given celecoxib 200mg and pregabaline 75mg twice daily
      started from 3 days before operation, and the last group was given placebo. The outcome was
      measured with VAS, knee ROM, and post-operative mobilization
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 1, 2015</start_date>
  <completion_date type="Actual">December 31, 2016</completion_date>
  <primary_completion_date type="Actual">December 1, 2016</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total Morphine Consumption</measure>
    <time_frame>Third day post-operative</time_frame>
    <description>In this study, morphine is given by patient control analgesia (PCA).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Post-operative Pain</measure>
    <time_frame>every morning [daily], up to 3 days</time_frame>
    <description>Measured and evaluated by Visual Analogue Scale (VAS). VAS score of 1-10. With the maximal of 10. Ranging from no pain to unbearable pain. Worst pain is in score 10.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Knee functional outcome</measure>
    <time_frame>every morning [daily], up to 3 days</time_frame>
    <description>Measured by active knee range of motion using goniometer. The outcome scale is in degree range of motion. The knee range of motion is 0 degree (total extension) to 135 degree (full flexion). The more range of motion degree, the better the result.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mobilization</measure>
    <time_frame>on the first day, standing on the second day, and walking on the third day</time_frame>
    <description>The patient is expected to be able to do sitting motion</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Acute Pain</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>celecoxib 400mg and pregabaline 150mg 1 hour before operation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>celecoxib 200mg and pregabaline 75mg twice daily started from 3 days before operation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 3</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>No treatment given</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Celecoxib and Pregabaline</intervention_name>
    <description>Single dose versus repetition dose</description>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_label>Group 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo</description>
    <arm_group_label>Group 3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  55-80 years old patients who come to orthopaedic polyclinic

          -  underwent TKA procedure

          -  have osteoarthritis

          -  consumed pain killer and anti inflamatory drugs routinely

        Exclusion Criteria:

          -  psychiatric disorder

          -  have history of renal disease

          -  histroy of chronic neurophatic

          -  have genu arthritis that caused by rheumatid arthritis and infection

          -  diabetic and obesity

          -  coagulopathy

          -  patients with severe pain that needed immediate analgesia regimen
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>April 2018</verification_date>
  <study_first_submitted>April 17, 2018</study_first_submitted>
  <study_first_submitted_qc>May 10, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 14, 2018</study_first_posted>
  <last_update_submitted>August 5, 2019</last_update_submitted>
  <last_update_submitted_qc>August 5, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 6, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Celecoxib</mesh_term>
    <mesh_term>Pregabalin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 10, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/32/NCT03523832/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

